Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion type Assertion NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_head.
- NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion description "[Our results show that gene expression profile differences in the PI3K-AKT signaling pathway identify two subgroups of high-grade endometrial carcinomas with different molecular alterations (PI3K-AKT pathway vs p53 alterations) that may have distinct roles in endometrial carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_provenance.
- NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion evidence source_evidence_literature NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_provenance.
- NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion SIO_000772 20173732 NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_provenance.
- NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion wasDerivedFrom befree-20140225 NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_provenance.
- NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_assertion wasGeneratedBy ECO_0000203 NP206189.RA5Fj1EGIMojtw03EyWUB4Vypi7_kH5bq7OSGN1eixpmA130_provenance.